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Abstract: 
Targeted drug delivery is a newer and less explored arena that has potential scope in 
tumor targeting because the regular chemotherapy has lethal effects on the normal cells also. Our 
present Work was an attempt to specifically target receptors on cancerous cells, especially the 
Folate Receptor (FR).  Folate is important for cells for DNA synthesis (1) and the tissues that 
rapidly divide require folate, cancer cells are no exceptions for this. To cope with the increased 
demand for the folate the cancer cells express greater FR on the cell surface. This very fact was 
our basis for the construction of our probe (1,2).  
Previous work in the group successfully demonstrated the use of dyes like Rhodamine to 
link folic acid in the construction of the probe. Dyes like Rhodamine have great advantages but 
are proven carcinogenic(3) so there is need for more safe linking agents like biotin which is a 
naturally occurring substance in human body. In this study, the concept of disulfide linkage was 
applied in order to link Folate Cysteinyl Dithiopyridil to Cysteinyl biotin as a Mass Spectoscopic 
Probe.  Because the mechanism in the study directly bonds via disulfide bond it makes linkage 
possible with various different types of moieties such including DNA.  Because FR is overly 
produced in malignant cells, several types of dyes and small molecules are being studied as to 
bind with FR. 
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Introduction: 
Cancer therapy: 
      Cancer till date remains one of the most challenging diseases to the medical society. Many 
years of Research and huge expenditure of human as well as monetary capital could only achieve 
so little and hence there is a lot to understand regarding this mind boggling disease. The most 
baffling problems with this disease are the eclectic nature of the cause of the disease. (4) 
Strategy: 
      Our aim was to make Folate probe with wider horizons and minimal side effects in this 
project cystenyle folate was attached to mixed disulfide coupling agents like aldrithirol this could 
be linked to dyes like rhodamine to increase the detection range visually(5)due to the 
carcinogenicity of rhodamine(3) it is being replaced by biotin capture probe. 
  
Folate receptors: 
      Use of Folate receptors as Trojan horse to deliver micro particles can be dated back to the 
year 1991 when Dr.Leamon demonstrated the uptake of the folate tagged particles by cells 
expressing folate.(1)  Folate is a must for DNA synthesis, repair, and methylation, also Folate is 
involved in biological reactions especially that utilize vitamins B6 and B12 as cofactors. Low 
concentrations of these vitamins can disturb one-carbon metabolism pathways [2] 
Glycosyl-phosphatidylinositol (GPI)
cell  physiology and pharmacology especially in m
folate/antifolate transport; three FR isoforms with differing relative affinities folates(6), Of the 
three isoforms of the Folate receptor the most common ones are FR alpha and beta. FR
called Folate receptor 1, or FOLR1) is over expressed by epithelial tumors and FR beta (also 
called Folate receptor 2 or FOLR2) is over expressed by non
affinity for folic acid (Kd ~ 1 nM)(7). The presence of folate receptors away from blood supply 
makes FRα inaccessible to the Folate conjugates administered intravenously and 
intraperitoneally. However, epithelial cancer cells that express FR
becomes expressed all over the cell surface, and at high levels, which make FR
intravenously. All this makes FRα
Biotin: 
      Biotin, also known as Vitamin H or Coenzyme R is a water
(vitamin B7). It is composed of a ureido (tetrahyd
tetrahydrothiophene ring. A valeric acid substituent is attached to one of the carbon atoms of the 
tetrahydrothiophene ring. 
Figure 1: structure of biotin 
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-anchored folate receptors (FR) have a crucial role to play in 
ediating cellular and transcellular 
-epithelial tumors FR
α lose this polarity, so FR
 an ideal candidate for therapeutic targeting on cancer cells (8).
-soluble B-complex vitamin 
roimidizalone) ring fused with a 
 
α (also 
α has a high 
α 
α accessible 
 
Courtesy: www.jbc.org/content/146/2/487.full.pdf
 
 
Aldrithiol is used as an oxidizing agent to reduce free sulfhydryl to form di sulfide bonds(8). 
Aldrithiol here is employed to bind with cystenyl folate and form a disulfide linkage with biotin. 
The probe was fabricated by forming a disulfide
Cysteinyl biotin. 
 
Figure 2: structure of aldrithiol (or)
Courtesy: http://www.sigmaaldrich.com/catalog/product/aldrich/143057?lang=en&region=US
Materials and Instruments: 
Materials:  
       99.9% Methanol (MeOH, from Fischer Scientific, Batch# 085072), 
(DMSO, from Sigma-Aldrich, Batch# 11696DK), 99% Diisopropylethylamine (DIPEA, from 
Sigma-Aldrich, Batch# 33396AK), 99.9% Methanol (MeOH, from Fischer Scientific, Batch# 
085072), 99.9% Piperidine (from Sigma
Dimethylformamide HPLC Grade (DMF, from Sigma
Acetonitrile (CAN from Burdick & Jackson, Batch# 5953), High Purity Water (H
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 bond between Folate Cysteinyl Dithiopyridil to 
 
 2,2'-Dipyridyldisulfide. 
Dimethylsulfoxide 
-Aldrich, Batch# 11329BJ), 99.9% N,N, 
-Aldrich, Batch# 12067TH), High Purity 
 
2O, from 
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Burdick & Jackson, Batch# Z360), 98% Aldrithiol-4 (Sigma Aldrich.), H-Cys(Trt)-2-CITrt resin 
(from NovaBiochem, Batch# A35853),  Biotin  , Phosphate buffer saline (PBS GSU Science 
Dept),  Ammonium bicarbonate (buffer), Thiol Cleavage Reagent(GSU Science Dept), PyBOP 
(from Novabiochem Batch# S5198009), 99.9% Methanol (MeOH, from Fischer Scientific, 
Batch# 085072). 
Instruments: 
HPLC (Hewlett Packard series 1050) with Semi-preparative column (C18 5 µm, 10x 
250mm Serial 9-122A), Legend Micro 17 Centrifuge (Thermo Scientific), Rotary Evaporator 
(Wilmad Labglass serial WG-EV311), Lyophilizer (GSU Science Dept.). 
Method and Analysis: 
Synthesis of Folate Cysteinyl Dithiopyridil 653 (FCD): 
            Weighed 0.0174g of Aldrithiol-4 into a 1.5ml Agilent capped vial, then weighed 0.220g 
of Folate Cysteine and added to the same vial. Then 300ul of DMSO was added and a small stir-
bar. Covered the vial with aluminum foil and spun for about 18 hours at low speed. This solution 
was labeled FCD-STD the covered in aluminum foil in a fridge at 2º for 72 hours. 
LC Analysis and Purification of FCD: 
      A 1050 Series Hewlett Packard HPLC with DAD and Regel Semi-Preparative column in 
conjugation was used with acetonitrile and ammonium bicarbonate buffer for separation. Peak 
intensities were ideal at wave length of 365nm, purification was done based on the 365 nm 
Chromatogram.  Folate Cysteine has maximum absorbance at 280nm under UV spectrum. 
280nm chromatogram was also monitored. To remove insoluble species FCD-STD was 
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centrifuged. To 10 fold dilution of supernatant FCD-STD DMSO was added to makeup to 100 
µl, and 10µl was injected. 
Following conditions were followed with the time increment. 
Time  Ammonium Bicarbonate Acetonitril Flow rate 
0 min 99% 1% 1ml/min 
30 min 70% 30% 1ml/min 
40 min 50% 50% 1ml/min 
50 min 30% 70% 1ml/min 
  
Three main peaks were eluted, the smallest peak represents the non-reacted Folate Cysteine, the 
intermediate peak represents the FCD and the peak at 56.1 min represents the excess aldrithiol. 
The peak at 27.7 min was collected into 20ml vial and labeled FCD (Folate Cysteinyl 
Dithiopyridil purified) covered in aluminum foil and stored in fridge at 2º for 72 hrs. 
Lyophilization and LCMS analysis of FCDp:  
      Liquid nitrogen was taken and the vial containing purified FCD was submerged into it.  The 
cap was removed and the opening was securely covered with a filter paper and lyophilized. A 
1.25µl sample was taken into auto-injector injection vial to check that predicted compound was 
formed. The sample was injected to an Agilent 1050 series LC-DAD-MS Ion Trap with negative 
ion mode monitoring between 300 and 1000 Dalton. Significant peaks was not found due to low 
concentration so 30µl was injected and monitored at wavelength 280, 254 and 230 nm. Total ion 
chromatogram of lyophilized FCD showed the sodium adduct. 
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Synthesis of PEG Biotin (CB): 
      Filtered syringe of 3ml was taken and plunger was removed, 0.0133g of PEG resin was 
added to the syringe and the plunger was replaced. The resin was rinsed thrice with 1ml of 
Dimethylformamide (DMF).  Then 1 ml of Dimethylformamide was taken into the syringe and 
vortexed at low speed for 20 minutes to swell the resin. After swelling, DMF was released and 
1ml of 20% piperidine in DMF was added and vortexed for 5 minutes at low speed. This step 
was repeated three times. 0.0100g of Biotin was added to ependorf tube during the third wash 
with 20% piperidine. Then 3µl of Diisopropylethylamine (DIPEA) and 0.5ml of DMF was added 
to this tube.  The ependorf tube was vortexed lightly and transferred to the filtered pipette. 
      Syringe containing resin and biotin was covered with an aluminum foil and vortexed for 85 
minutes to react. Then the syringe was washed five times with DMF and three times with 
Dichloromethane and finally washed three times with methanol. Undesirable disulfide formation 
due to exposure to oxygen was reduced by drying the pipette with nitrogen. The syringe was 
covered with parafilm and covered with aluminum foil and labeled as PEG-BIOTIN and 
refrigerated for 72 hours at 2ºC. 
Synthesis of Folate-BIOTIN from FCDp & PEG-BIOTIN: 
      Purified FCD, 200µl of DMSO and 5µl of DIPEA was added to PEG-biotin and the mixture 
is mixed with micro-stirbar for 24 hours. The sample was labeled Follate-Biotin, covered with 
aluminum foil and refrigerated for 72 hours at 2ºC. 
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Synthesis of Folate-Biotin flowchart: 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
Step1:  0.174g Aldrithiol + 0.220g Folate Cystine was mixed. 300µL DMSO was 
added after and was mixed for 18 hr with slow agitation. 
Step 2: Centrifugation of mixture at 1000rpm. Supernatant was collected and 
diluted to 10 fold with DMSO (10µL to 100µL). Injected the mixture to semi 
preparative HPLC for purification. 
Step 4: 0.1000gm of CRT and 0.0167gm of PyBOP was weighed into ependorf 
tube+3µL of DIPEA + 0.5ml of DMF was mixed. This mixture was added to the 
contents in step3 and mixed approx. for 1-5 hours 
Step3: 0.0133gm of PEG resin was weighed into a syringe and rinsed three times 
with DMF and allowed to swell for 20 min. Rinsed with 1ml of 20% piperidine 3 
times for 5 min each. 
Step 5: Contents were washed with DMF, DCM nad Methanol 5, 3 and 3 times 
respectively. Contents were dried using Nitrogen. Then added 1ml of Thiol cleavage 
reagent and mixed for 70 min   
Step 6: Contents were rotary evaporated and washed with Di-ethyl-ether and 
evaporated di-ethyl-ether. Labeled as PEG-Biotin. 
Step 7: FCD and PEG-BIOTIN was mixed in equal ratios in a vial with 200 µL of 
DMSO 
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Results and Discussion: 
Synthesis and analysis of FCD: 
      Folate Cysteinyl Dithiopyridil was purified using preparative HPLC as it has impurities like 
aldrithriol and an unreacted folate cysteine. C18 column was used for purification, most nonpolar 
species will elute last in the chromatogram. FCD peak was eluted at approx. 30 minutes. By 
observing the UV spectrum of significant peaks it was evident that among three peaks middle 
peak at 30 minutes was FCD. Order of elution was also useful in predicting this FCD peak. 
Experiment was designed to have excess aldrithiol and limited folate cysteine. This is noticed in 
chromatogram with unreacted folate cysteine appearin first with smallest relative area, FCD 
intermediate in area and aldrithiol at last with the highest area. 
      The product was further confirmed by LCMS analysis in positive ion mode of purified FCD 
based on the molecular ion (M+H) at 652 and its quaternary sodium adduct formation at 673. 
FCDp was further reacted with PEG-Biotin to synthesize folate-Biotin, this was separated using 
HPLC. 
Conclusion: 
      Purified FCD was synthesized with simple syringe based method. FCD was purified 
successfully by using preparative HPLC and the compound was evaluated by LCMS analysis. By 
using FCDp, folate biotin was synthesised successfully. But was not confirmed with mass spec. 
Method used for synthesis was simple, safe and can be performed in most laboratories with 
minimum resources which are cost effective.   
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Figure 6: Chromatogram of FCD Injection. Peak around 30 minutes was determined to be 
FCD and the ending significant peak represents aldrithiol. 
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Figure 7: Collecting FCD peak at 30 minutes. 
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Figure 8: Purified FCD. 
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Figure 9: Centrifuge (Thermo Scientific). 
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Figure 10: Basic schematic of first part of reaction to make FCD from Folate Cysteine and 
Aldrithiol. 
Figure 11: Basic schematic of second part of reaction to make FCD bound to a drug, 
imaging reagent DNA etc. via a disulfide bond. 
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